Additional support for this conclusion comes from the finding that cyclin D1 overexpression in LNCaP prostate cancer cells increased the fraction of S-phase cells and decreased growth factor requirements for their proliferation [71]. The gene discussed is CCND1; the disease is prostate cancer.